Release Date: 25/10/18 08:48 Summary: Quarterly Activities Report & Appendix 5B Price Sensitive: Yes Download Document 342.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%